Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 265 | 317 | 0 | 191 | 328 |
| Cost of Goods | 217 | 262 | N/A | 92 | 174 |
| Gross Profit | 48 | 55 | N/A | 99 | 154 |
| Operating Expenses | 3,049 | 2,775 | 0 | 3,090 | 2,233 |
| Operating Income | -2,784 | -2,458 | N/A | -2,899 | -1,905 |
| Other Income | -152 | 56 | 0 | 1,078 | 306 |
| Pre-tax Income | -2,936 | -2,402 | 0 | -1,821 | -1,599 |
| Net Income Continuous | -2,936 | -2,402 | N/A | -1,821 | -1,599 |
| Net Income | $-2,936 | $-2,402 | $N/A | $-1,821 | $-1,599 |
| EPS Basic Total Ops | -0.03 | -0.02 | N/A | -0.02 | -0.02 |
| EPS Basic Continuous Ops | -0.03 | -0.02 | N/A | -0.02 | -0.02 |
| EPS Diluted Total Ops | -0.03 | -0.02 | N/A | -0.02 | -0.02 |
| EPS Diluted Continuous Ops | -0.03 | -0.02 | N/A | -0.02 | -0.02 |
| EPS Diluted Before Non-Recurring Items | -0.03 | -0.02 | N/A | -0.02 | -0.02 |
| EBITDA(a) | $-2,728 | $-2,400 | $N/A | $-2,934 | $-1,764 |